Literature DB >> 35532346

Self-Assembly of Intelligent Nanoplatform for Endogenous H2S-Triggered Multimodal Cascade Therapy of Colon Cancer.

Lan Yang1, Yupeng Zhu1, Liuqing Liang1, Chenhui Wang1, Xinghai Ning2, Xuli Feng1.   

Abstract

The specific in situ generation and activation of therapeutic agents with high spatiotemporal precision is expected to revolutionize cancer treatment. Here, we develop an intelligent nanoplatform (termed as NP-Cu), which is constructed by assembling photosensitizer chlorin e6 (Ce6), hypoxia-responsive prodrug banoxantrone (AQ4N) with clickable dibenzocyclooctyne (DIBO) functionalized lysine (D-K), and cyclen-Cu2+ complex, for improving combination anticancer therapy. Cyclen-Cu2+ complex-induced photodynamic therapy (PDT) quenching in NP-Cu can be effectively and selectively activated by tumor-overproduced hydrogen sulfide (H2S). More importantly, the reaction of endogenous H2S with Cu2+ can generate photothermal agent copper sulfide (CuS) for photothermal therapy (PTT). Furthermore, with the activation of PTT and PDT, intracellular hypoxic stress is amplified to trigger AQ4N-associated chemodynamic therapy (CDT), leading to light-enhanced cascade therapy of PDT, PTT and CDT. Therefore, we present a simple and practical strategy for developing pathological stimuli responsive combination therapy, which has the potential of advancing precision cancer medicine.

Entities:  

Keywords:  endogenous H2S; precision cancer medicine; self-assembly; stimuli-responsive nanoplatform; trimodal cascade therapy

Mesh:

Substances:

Year:  2022        PMID: 35532346     DOI: 10.1021/acs.nanolett.2c01131

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  1 in total

1.  Programmable Drug Release from a Dual-Stimuli Responsive Magnetic Metal-Organic Framework.

Authors:  Muhammad Usman Akbar; Muhammad Badar; Muhammad Zaheer
Journal:  ACS Omega       Date:  2022-08-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.